Navigation Links
ARVO launches new journal on translational research
Date:1/13/2012

Rockville, MD The Association for Research in Vision and Ophthalmology (ARVO) launched its third journal, Translational Vision Science & Technology (TVST), with an open call for manuscript submissions this month. TVST is an online only, peer-reviewed journal emphasizing multidisciplinary research that bridges the gap between basic research and clinical care.

The new journal will publish manuscripts in English language by scientists and clinicians with diverse backgrounds ranging from basic chemistry to ophthalmic surgery, bringing together research that, until now, often has been published in journals other than those directly related to ophthalmology.

"TVST's focus on translational research is unique, as is the attempt to bring innovators and facilitators together through a periodical that has extremely high standards," said TVST's editor-in-chief, Marco Zarbin, MD, PhD, FARVO. "Our goal is to create a venue in which these innovations can be subject to rigorous peer review and, having been strengthened by that process, make their way into the public domain and directly to the attention of an appropriate audience of fellow innovators and potential scientific and business partners."

Zarbin is the chair of the Institute of Ophthalmology and Visual Science, New Jersey Medical School and chief of ophthalmology at University Hospital in Newark, N.J. He is a professor of ophthalmology and neuroscience and holds the Alfonse A. Cinotti, MD/Lions Eye Research Chair in the Department of Ophthalmology. In addition to his current role with TVST, Zarbin previously served as an associate editor of ARVO's Investigative Ophthalmology and Visual Science (IOVS) journal.

Appointed by ARVO Board of Trustees, Zarbin is joined by a team of highly-qualified associate editors and editorial board members from across the globe in publishing the new journal, which will cover a broad spectrum of work, including:

  • Applications of stem cell technology for regenerative medicine
  • Development of new animal models of human diseases
  • Tissue bioengineering
  • Chemical engineering to improve virus-based gene delivery
  • Nanotechnology for drug delivery
  • Design and synthesis of artificial extracellular matrices
  • Development of a true microsurgical operating environment
  • Refining data analysis algorithms to improve in vivo imaging technology
  • Results of Phase 1 clinical trials
  • Reverse translational ("bench to bedside") research

"TVST will be an excellent complement to ARVO's other journals IOVS and Journal of Vision by providing thorough review yet timely dissemination of cutting-edge research aimed at novel treatment of vision-threatening diseases," said ARVO President Jeffrey H. Boatright, PhD, FARVO.

The inaugural issue of TVST is planned for release this spring. For information on the manuscript submission process, visit www.arvo.org/tvstjournal.


'/>"/>

Contact: Katrina Norfleet
knorfleet@arvo.org
240-221-2924
Association for Research in Vision and Ophthalmology
Source:Eurekalert

Related biology news :

1. Malaysian Prime Minister launches company for supply of biomass from oil palm
2. Allen Institute for Brain Science launches new atlas, adds new data and tools to others
3. RV Polarstern launches 28th Antarctic season
4. Scripps launches whole genome sequencing study to find root causes of idiopathic diseases
5. American Life Sciences Innovation Council Launches
6. FDA grant launches Atlanta Pediatric Device Consortium
7. NIH launches research program to explore health effects from climate change
8. MedNet Solutions Launches the iMedNet CRO Partner Program
9. MSU professor launches new field of water research, nets $2.2 million NSF grant
10. Elsevier launches Current Opinion in Virology
11. SIB launches next generation ExPASy, an entry portal to indispensable bioinformatics resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... YORK , April 5, 2017 Today ... is announcing that the server component of the HYPR ... known for providing the end-to-end security architecture that empowers ... HYPR has already secured over 15 million ... makers including manufacturers of connected home product suites and ...
(Date:3/30/2017)... -- On April 6-7, 2017, Sequencing.com will host the world,s ... at Microsoft,s headquarters in Redmond, Washington ... health and wellness apps that provide a unique, personalized ... is the first hackathon for personal genomics and the ... the genomics, tech and health industries are sending teams ...
(Date:3/28/2017)... -- The report "Video Surveillance Market by ... Devices), Software (Video Analytics, VMS), and Service (VSaaS, Installation ... 2022", published by MarketsandMarkets, the market was valued at ... reach USD 75.64 Billion by 2022, at a CAGR ... considered for the study is 2016 and the forecast ...
Breaking Biology News(10 mins):
(Date:8/16/2017)... Ca (PRWEB) , ... August 16, 2017 , ... ... by changing into a different cell type. Many treatments for specific cancers, such ... prominent example of targeted treatment is androgen deprivation therapy for advanced prostate cancer. ...
(Date:8/16/2017)... ... 16, 2017 , ... Today, 3Bar Biologics Inc ., ... in funding from an impressive group of investors, including Rev1 Ventures, Maumee Ventures, ... this investment, 3Bar is broadening availability of its groundbreaking offering that uses naturally ...
(Date:8/16/2017)... , Aug. 16, 2017  This year,s edition of the Inc. 5000 ... life sciences workforce solutions, has made the list for the third year ... the nation,s fastest-growing private companies based on a set of quantitative metrics. ... includes the fastest-growing companies in the Bay State . ... Inc. 5000 ...
(Date:8/15/2017)... 2017 After spending the past two years building a ... collection, GeneFo now offers this platform to healthcare stakeholders (hospitals, foundations, ... adherence, and data collection vis a vis their members, under their ... launch of this offer. ... ...
Breaking Biology Technology: